{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:22:30Z","timestamp":1792290150194,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.critrevonc.2023.103953","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T20:05:31Z","timestamp":1678133131000},"page":"103953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"184","author":[{"given":"Xiao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2023.103953_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3892\/ol.2011.516","article-title":"Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy","volume":"3","author":"Abe","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2023.103953_bib2","first-page":"1","article-title":"Chemoradiation and the role of adjuvant chemotherapy in lymph nodal-metastatic cervical cancer","volume":"4","author":"Ali","year":"2018","journal-title":"J. Glob. Oncol."},{"issue":"9972","key":"10.1016\/j.critrevonc.2023.103953_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103953_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000521980","article-title":"Effect of adjuvant chemotherapy in stage III cervical cancer patients treated with concurrent chemoradiation: a multicenter study","volume":"45","author":"Atci","year":"2022","journal-title":"Oncol. Res. Treat."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103953_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2023.103953_bib6","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.3390\/curroncol29080415","article-title":"Is there a place for adjuvant chemotherapy in the treatment of locally advanced cervical cancer?","volume":"29","author":"\u010cerina","year":"2022","journal-title":"Curr. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103953_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ijrobp.2010.07.2006","article-title":"A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer","volume":"81","author":"Choi","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2023.103953_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2004.12.039","article-title":"Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I\/II study","volume":"97","author":"Chung","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2023.103953_bib9","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Duenas-Gonzalez","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib10","first-page":"19","article-title":"Definitive treatment for locally advanced cervical cancer: a retrospective analysis from a singe institution","volume":"28","author":"Duru Birgi","year":"2018","journal-title":"Uhod-Uluslar. Hematol."},{"issue":"7109","key":"10.1016\/j.critrevonc.2023.103953_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2023.103953_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1217838","article-title":"The impact of addition of consolidation chemotherapy to standard cisplatin-based chemoradiotherapy in uterine cervical cancer: matter of distant relapse","volume":"2019","author":"Fabri","year":"2019","journal-title":"J. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103953_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103953_bib14","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3390\/cancers13081880","article-title":"Adjuvant systemic therapy after chemoradiation and brachytherapy for locally advanced cervical cancer: a systematic review and meta-analysis","volume":"13","author":"Horeweg","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.103953_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103638","article-title":"A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer","volume":"172","author":"Horeweg","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103953_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4143\/crt.2012.44.2.97","article-title":"Phase II study of consolidation chemotherapy after adjuvant or primary concurrent chemoradiation using paclitaxel and carboplatin to treat high-risk early-stage or locally advanced cervical cancer","volume":"44","author":"Kim","year":"2012","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2006.07.005","article-title":"Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors","volume":"104","author":"Kim","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2023.103953_bib18","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","article-title":"Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III Trial JCOG0505","volume":"33","author":"Kitagawa","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2023.103953_bib19","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2021-0818","article-title":"Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer","volume":"18","author":"Kou","year":"2022","journal-title":"Future Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2023.103953_bib20","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2217\/fon-2021-0818","article-title":"Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer","volume":"18","author":"Kou","year":"2022","journal-title":"Future Oncol."},{"issue":"33","key":"10.1016\/j.critrevonc.2023.103953_bib21","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1200\/JCO.2004.00.0497","article-title":"Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study","volume":"23","author":"Lanciano","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103953_bib22","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1002\/cncr.33795","article-title":"Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years","volume":"127","author":"Lin","year":"2021","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103953_bib23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0360-3016(02)04405-X","article-title":"Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial","volume":"55","author":"Lorvidhaya","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib24","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e15","article-title":"Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB\/IVA cervical cancer patients","volume":"28","author":"Mabuchi","year":"2017","journal-title":"J. Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103953_bib25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/COC.0000000000000458","article-title":"The significance of para-aortic nodal size and the role of adjuvant systemic chemotherapy in cervical cancer: an institutional experience","volume":"41","author":"Manders","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103953_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.2021.39.15_suppl.LBA3","article-title":"Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: the randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)","volume":"39","author":"Mileshkin","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.critrevonc.2023.103953_bib27","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2009.21.8909","article-title":"Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study","volume":"27","author":"Monk","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103953_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103953_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2105\/AJPH.2020.305609","article-title":"Cochrane handbook for systematic reviews of interventions","volume":"110","author":"Nasser","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.critrevonc.2023.103953_bib30","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2023.103953_bib31","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.4103\/ijmpo.ijmpo_171_17","article-title":"Toxicity profile of double-agent adjuvant chemotherapy after concurrent chemoradiation and brachytherapy in locally advanced cervical cancer: comparison with standard chemoradiation protocol","volume":"40","author":"Pandya","year":"2019","journal-title":"Indian J. Med. Paediatr."},{"key":"10.1016\/j.critrevonc.2023.103953_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.745522","article-title":"Neoadjuvant and adjuvant treatments compared to concurrent chemoradiotherapy for patients with locally advanced cervical cancer: a Bayesian network meta-analysis","volume":"12","author":"Qiao","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer J. Clin."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103953_bib34","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103953_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2012.01.033","article-title":"Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma","volume":"125","author":"Tang","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103953_bib36","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103953_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103953_bib38","first-page":"558","article-title":"Comparison of the curative effect and safety of consolidation chemotherapy after concurrent chemoradiotherapy with concurrent chemoradiotherapy alone for locally advanced cervical cancer","volume":"39","author":"Tu","year":"2018","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"35","key":"10.1016\/j.critrevonc.2023.103953_bib39","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","author":"Vale","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103953_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ygyno.2006.03.060","article-title":"Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix \u2013 final results of a prospective phase II-study","volume":"103","author":"Vrdoljak","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103953_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mri.2022.05.019","article-title":"MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone","volume":"91","author":"Wei","year":"2022","journal-title":"Magn. Reson Imaging"},{"key":"10.1016\/j.critrevonc.2023.103953_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1073274821989307","article-title":"A multi-institutional retrospective analysis of oncologic outcomes for patients with locally advanced cervical cancer undergoing platinum-based adjuvant chemotherapy after concurrent chemoradiotherapy","volume":"28","author":"Wu","year":"2021","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103953_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.31083\/j.ejgo4205152","article-title":"Comparison between curative concurrent chemoradiotherapy followed by adjuvant chemotherapy and curative concurrent chemoradiotherapy alone in patients with locally advanced cervical carcinoma: a meta-analysis","volume":"42","author":"Yang","year":"2021","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ijgc-2018-000022","article-title":"Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer","volume":"29","author":"Yavas","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103953_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ijgc-2020-001230","article-title":"Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis","volume":"32","author":"Yuan","year":"2022","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:47:10Z","timestamp":1760903230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":45,"alternative-id":["S1040842823000410"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103953","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103953"}}